Liraglutide
Also known as: Victoza, Saxenda
Liraglutide is a GLP-1 receptor agonist studied for blood-glucose regulation in type 2 diabetes and for effects on appetite and body weight. Its shorter half-life relative to weekly agents corresponds to commonly reported once-daily use. This entry is informational and is not a recommendation to use the compound.
At a glance
| Category | GLP-1 & Incretins |
|---|---|
| Class | glp1-agonist, incretin |
| Half-life | 13 hours |
| Typical route | subcutaneous |
| Common vial strengths | 6 mg, 18 mg |
| Storage | Commonly stored refrigerated before first use and kept cool afterward, protected from light. |
Elimination curve
Full clearance milestones on the Liraglutide half-life page.
Doing the vial math? The Liraglutide reconstitution calculator converts mg to insulin-syringe units, free and without an account.
Questions, answered.
What is Liraglutide?
What is Liraglutide's half-life?
Is Liraglutide the same as Victoza or Saxenda?
What do people log alongside Liraglutide?
Educational information for people who track their protocols — not medical advice, and never a recommendation to use any compound. Always work with a qualified healthcare provider.
Track Liraglutide with one-tap dose logs, estimated level charts, site rotation, and reminders — free for your first 3 days.